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Cardiac Autonomic Activity in Patients With Transient
Left Ventricular Apical Ballooning
To the Editor: Transient left ventricular apical ballooning (AB) is
characterized as a reversible apical balloon-like left ventricular wall
motion abnormality. In contrast to patients with acute myocardial
infarction (MI), patients with AB do not have obstructive coronary
heart disease (CHD) and experience almost complete recovery of
cardiac function. Excess sympathetic activity and cardiac sympa-
thovagal disbalance seems to play a major part in the origin of this
syndrome. Experimental data suggest high catecholamine plasma
concentrations and activation of cardiac adrenoreceptors (1); how-
ever, cardiac sympathovagal activity has not yet been studied in
patients with AB. The aim of the present study was to investigate
differences in reflex and tonic sympathovagal activity in patients
with AB compared with patients with successfully reperfused acute
anterior MI.
We investigated 11 consecutive patients undergoing coronary
angiography with clinical signs of ST-segment elevation acute MI
who fulfilled morphologic criteria of AB in the left ventricular
angiography: balloon-like left ventricular wall motion abnormality
at the apex and absence of obstructive CHD. Exclusion criteria
were history of a previousMI or structural/valvular disease, pheochro-
mocytoma, myocarditis, atrial fibrillation, left bundle branch block,
pacemaker rhythm and rhythm other than sinus, and invalid
Holter electrocardiograph (ECG) recordings. Nine of 11 consec-
utive age-, gender-, BMI-, and left ventricular function-matched
patients with ST-segment elevation acute MI who underwent
successful direct percutaneous coronary intervention (PCI) of a
proximal total occlusion of the left anterior descending artery
within 12 h after onset of chest pain served as a control group.
All patients underwent 24-h ECG recordings on the third day
after hospital admission. Time and frequency domain heart rate
variability (HRV) parameters were measured according to the Task
Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology (2). Heart rate
turbulence (HRT) was analyzed after single ventricular premature
beats, as previously described (3).
Continuous and categorical variables were compared with the
Student t test and the Mann-Whitney U test. Data are presented
as mean SD. A two-tailed significance level of 0.05 was used for
the analyses.
Among the 11 patients with AB, 9 fulfilled the clinical and
technical inclusion criteria. There were no significant differences
regarding demographic variables, left ventricular ejection fraction,
medication, and TIMI risk score (4) between groups (Table 1).
Peak cardiac enzyme release was significantly higher in MI
patients. Measurements of HRT and HRV are depicted in Table 2.
Standard deviation of NN intervals (SDNN) and high-frequency
component were significantly higher in the AB group. Low-
frequency/high-frequency ratio revealed a shift towards sympa-
thetic predominance in MI patients compared with AB patients.
The AB patients also exhibited significantly higher values for
turbulence slope. Mean RR-intervals tended to be higher in AB
patients.
The present study is the first to investigate cardiac sympatho-
vagal activity in patients with AB. The principal finding was that,
in contrast to matched patients with reperfused anterior MI, tonic
and reflex autonomic activity is preserved in the subacute phase of
AB. This observation might suggest a rapid attenuation of cardiac
autonomic impairment in the subacute phase of AB, resulting in
electrical stability and reduced oxygen demand of the affected
myocardium.
Although AB clinically mimics ST-segment elevationMI, invasive
and laboratory findings suggest a nonischemic cause of the disease.
Recent data suggest that excess sympathetic activity play a major role
in the origin of the syndrome. In the majority of patients, history of
emotional or physiological stress was observed immediately before the
onset of the acute event. Interestingly, there are contrary results, thus
far, regarding circulating catecholamine concentrations in AB (5).
Owa et al. (6) suggested apical disturbance of cardiac sympathetic
innervation and perfusion/innervation discrepancy as the origin of
AB. The hypothesis of excess sympathetic activation in AB is
Table 1. Baseline Clinical Characteristics
Apical Ballooning
(n  9)
Myocardial Infarction
(n  9) p Value
Age (yrs) 64.0  9 61.7  2 NS
Female gender (n) 8 (90%) 8 (90%) NS
Body mass index (kg/m2) 24.6  4 24.9  4 NS
LV ejection fraction (%) 44.9  6 47.1  9 NS
Initial troponin T (ng/ml) 0.19  0.4 0.32  0.6 NS
Peak troponin T (ng/ml) 0.42  0.3 10.1  8.1 0.001
Peak creatine kinase (U/l) 241  166 1,355  1,210 0.001
Peak lactate dehydrogenase (U/l) 211  67.6 807  624 0.001
One-/two-/three-vessel disease (n) (0/0/0) (7/2/0) 0.001
Hypercholesterolemia (n) 2 (22%) 5 (56%) NS
Current smoker (n) 2 (22%) 5 (56%) NS
Hypertension 5 (55%) 5 (55%) NS
Diabetes mellitus 1 (11%) 2 (22%) NS
TIMI risk score (9) 3.9  1.7 4.2  1.8 NS
Medication at time of Holter recording
Beta-blocker (n) 9 (100%) 9 (100%) NS
ACE inhibitor (n) 9 (100%) 8 (88%) NS
ACE  angiotensin-converting enzyme; LV  left ventricular; TIMI  Thrombolysis In Myocardial Infarction.
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supported by experimental data, showing that stress induces reversible
left ventricular apical hypokinesia (1). Furthermore, in the apical
region of the heart, a higher adrenergic receptor density and myocar-
dial responsiveness to adrenergic stimulation has been described (7).
The findings of the present study support the hypothesis that, not
increased sympathetic autonomic activity directed to the heart, but
rather, increased myocardial adrenergic responsiveness might be the
underlying pathophysiologic mechanism. Indeed, low-frequency
component, associated with cardiac sympathetic modulation, was not
significantly elevated in AB. Furthermore, sympathovagal balance and
baroreflex function were even more preserved in patients with AB.
Therefore, the absence of the deleterious effects on reflex afferent and
efferent autonomic function and tonic autonomic modulation in
transient left ventricular AB suggest a preserved cardiac autonomic
control. The blunted turbulence slope in patients with MI either
suggests a faster recovery of baroreflex control in AB patients or a
significant impact of coronary artery disease (CAD) on autonomic
reflexes beyond acute myocardial ischemia.
Complete reperfusion of the infarct-related artery is associated
with a significant restoration of baroreflex sensitivity, whereas
incomplete reperfusion causes persistent impairment of baroreflex
response, reflecting a more severe microvascular dysfunction (8).
Despite angiographic evidence of complete epicardial perfusion,
patients with MI, in contrast to patients with AB, might have a
mismatch between vascular patency and myocardial perfusion.
Accordingly, microvascular dysfunction has been previously ruled
out also by measurements of coronary flow reserve, contrast
echocardiography, and positron emission computer tomography in
patients with AB (9). Serum cardiac troponin T, which is related
to the amount of microvascular damage and dysfunction, was also
not significantly elevated in AB patients. Therefore, significantly
higher turbulence slope, surrogate marker for baroreflex sensitivity,
might reflect a significant rapid improvement of the transient
perfusion/innervation mismatch in AB patients.
The present study is the first to demonstrate significant differ-
ences of cardiac autonomic modulation in patients with acute
ST-segment elevation MI with and without obstructive CAD. In
contrast to AB patients, there is a delayed recovery of tonic and
reflex autonomic nervous modulation in MI patients. These
differences in autonomic modulation represent a previously unrec-
ognized phenomenon that needs further investigation for under-
standing the underlying pathophysiological mechanisms in AB.
Improved cardiac autonomic function might explain, in part, the
rapid recovery of left ventricular function and favorable prognosis
in patients with AB.
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Letters to the Editor
Impact of Stent Fractures
Following Femoropopliteal Stenting
With great interest we read the prospective registry of stent
fractures after femoropopliteal stenting in a recent issue of the
Journal (1). The observed rate of fractures of nitinol stents, which
represent an essential progress compared with the use of balloon-
expandable stents or wall stents, is astonishingly high in contrast to
other studies and our own experience. We therefore regard it as
essential to make some critical comments to avoid a too high
assessment of the single-center observation.
The described results touch on an observational series in a single
center, laid out prospectively and described as a register. However,
a registry demands an external monitoring and evaluation of the
results. This did not happen. Three types of stents, in varying
numbers and of different lengths, were inserted into the vessels.
In 93 patients, 121 extremities were treated interventionally;
261 stents were implanted. Moreover, the mean length of the
stented segments was different in all, with the highest in the
Luminexx stent with 168 mm (SD 94 mm). This is remarkably
high, because, with a maximum stent length of 120 mm, more than
two stents had to be used in various patients. But this is explicitly
mentioned under precautions in the instructions for use.
Furthermore, in the publicized pictures of stent fractures of the
original study and at different presentations at international con-
gresses, only Luminexx stents are exposed. This is probably
explained by the fact that a Luminexx stent, in comparison to a
SMART or SelfX stent, is much more visible under X-ray.
However, this can lead to a wrong assessment and overestimation
of stent fractures. Furthermore, the color-coded duplex sonogra-
phy was only used for stent patency. Therefore, the visual assess-
ment of the stent has to be checked externally or carried out
independently.
Finally, in different illustrations, stent implantations were
shown without overlapping and also in the distal third of the
superficial femoral artery (SFA) and in the first and second
segment of the popliteal artery. In turn, this is obviously listed as
a contraindication in the instructions for use. Therefore, the
progress of the usage of nitinol stents in the SFA should not be
questioned by an observational series done at a single center.
Preferably, one should await the results of scientifically relevant
prospective controlled and randomized studies.
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Bridging the Resource Gap in Heart
Failure Expertise and Management: The
Underacknowledged Role of Nurse Specialists
Recent studies in the Journal have raised concerns regarding the
limited availability of heart failure (HF) specialists. Because HF
care now incorporates increasingly complicated strategies and
technologies, and because the number of HF patients is burgeon-
ing, capable and specialized providers are in greater demand. The
backbone of management must not be forgotten, however, and, as
Konstam (1) suggests, “highly specialized clinicians” will clearly be
needed to master the evaluation of the HF patient and the timing
of HF interventions. The foundation of HF care rests upon the
cognitive aspects: identifying and diagnosing the problem, using
evidence-based medications, maintaining appropriate intravascular
volume status, educating patients about the disease process, and
considering device-related and end-of-life issues. Those termed
“plumbers” and “electricians” by Naccarelli (2) should not replace,
but augment, those who provide the cognitive aspects of HF care.
However, economic remuneration and exciting advances in
procedural therapies have led many cardiologists away from the
core of HF management, resulting in a shortage of HF providers.
Less attention has been paid to the comprehensive strategies
provided by specially trained nurses who have shown improved HF
outcomes in the past and should not be overlooked as other
solutions are posed. When studied in the context of multidisci-
plinary teams, often led by cardiologists, nurse specialists have been
shown to contribute significantly to improving outcomes. The
review by McAlister et al. (3) of 29 trials has identified that one of
the three “crucial” elements in a successful program is the use of
specially trained HF nurses. What role do nurse specialists have in
HF management? They are able to monitor patients’ intravascular
volume status, titrate HF medications, triage and often avert
admissions with appropriate telemanagement, and educate patients
and families. Additionally, nurse specialists assist with complex
levels of care when faced with end-stage strategies of transplant,
end-of-life issues, or mechanical support.
Finally, the growing global burden of HF necessitates the
investigation into alternative methods of providing coordinated,
integrated, and focused care for patients. Though a clear need
exists for subspecialized care of HF patients so that all appropriate
options can be provided, the role that nurse specialists play in
managing patients across the spectrum should be fully acknowl-
edged. Nurse specialists should be part of the solution to the
growing HF provider shortage, as multidisciplinary HF team
1961JACC Vol. 46, No. 10, 2005 Correspondence
November 15, 2005:1957–64
